<?xml version="1.0" encoding="utf-8"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Lobe Sciences Ltd</title><link>https://investorshangout.com/Lobe-Sciences-Ltd-LOBEF-94179/</link><description><![CDATA[Lobe Sciences Ltd (LOBEF)]]></description><language>en-us</language><pubDate>Mon, 19 Oct 2026 00:18:00 GMT</pubDate><copyright>Copyright InvestorsHangout.com</copyright><atom:link href="https://investorshangout.com/Lobe-Sciences-Ltd-LOBEF-94179/" rel="self" type="application/rss+xml"/><item><title>pennyMoMo: (CSE: $LOBE) (OTCQB: $LOBED)- Lobe Sciences Ltd. Announces Regulatory and Clinical Development Plans</title><link>https://investorshangout.com/post/view?id=6434301</link><guid>https://investorshangout.com/post/view?id=6434301</guid><description><![CDATA[pennyMoMo
]]></description><pubDate>Thu, 07 Jul 2022 17:39:20 GMT</pubDate></item><item><title>pennyMoMo: $GTSIF; CSE / $LOBED - Lobe Sciences plans to advance to Phase 1 PTSD study in second half of 2022 w</title><link>https://investorshangout.com/post/view?id=6424898</link><guid>https://investorshangout.com/post/view?id=6424898</guid><description><![CDATA[pennyMoMo
]]></description><pubDate>Tue, 21 Jun 2022 14:01:33 GMT</pubDate></item></channel></rss>